The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients
El-Hanafi, M., El-Brashy, A., Ibrahim, N., khater, H., Mohammed, S. (2023). The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients. EKB Journal Management System, 8(7), 1-6. doi: 10.21608/bjas.2023.216940.1188
Mounir El-Hanafi; Abd El-Wahab El-Brashy; Noha Ibrahim; Hamada khater; Shimaa Mohammed. "The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients". EKB Journal Management System, 8, 7, 2023, 1-6. doi: 10.21608/bjas.2023.216940.1188
El-Hanafi, M., El-Brashy, A., Ibrahim, N., khater, H., Mohammed, S. (2023). 'The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients', EKB Journal Management System, 8(7), pp. 1-6. doi: 10.21608/bjas.2023.216940.1188
El-Hanafi, M., El-Brashy, A., Ibrahim, N., khater, H., Mohammed, S. The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients. EKB Journal Management System, 2023; 8(7): 1-6. doi: 10.21608/bjas.2023.216940.1188

The Relationship between Serum Pentraxin-3 Level and Disease Activity and Severity in Rheumatoid Arthritis Patients

Benha Journal of Applied Sciences
Article 1, Volume 8, Issue 7, July 2023, Page 1-6  XML PDF (340.79 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2023.216940.1188
View on SCiNiTO View on SCiNiTO
Authors
Mounir El-Hanafi1; Abd El-Wahab El-Brashy1; Noha Ibrahim1; Hamada khater2; Shimaa Mohammed email 1
1Rheumatology,Rehabilitation and Physical Medicine Dept., Faculty of medicine,Benha University
2Radiology Dept. , Faculty of medicine, Benha University
Abstract
Background: Pentraxin 3 (PTX3) is an inflammatory marker, a member of long pentraxin superfamily that has an important role in inflammation and immunity. Objectives: The aim of this study was to measure serum pentraxin 3 levels in RA patients and evaluate their relation with different disease parameters. Methods: We measured serum PTX3 levels in 40 women with RA and 40 female control subjects. PTX3concentrations were measures by ELISA. Results: Median serum level of pentrexin 3 was significantly higher in RA patients compared to healthy controls (36.4 ng /ml vs 12.4 ng /ml respectively) (p < 0.001). There was a significant difference in serum PTX3 levels according to the disease activity grades. PTX3 concentration was also significantly correlated with ESR(r = 0.506, p=0.001), CRP(r = 0.780, p < 0.001) and Larsen Score (r = 0.784, p < 0.001). There was no significant difference in serum PTX3 levels and RF& anti-CCP positive and negative patients (P >0.05). No significant correlation (p>0.05) was found between serum Pentraxin-3 and age (r = 0.095), BMI(r = 0.059), disease duration (r = 0.048) and RF titer(r = 0.240). Conclusions: PTX3 can be considered as a sensitive non-invasive biomarker reflecting the disease activity and radiological damage in RA patients.
Keywords
RA: Rheumatoid; Arthritis; PTX3; Pentraxin 3
Statistics
Article View: 36
PDF Download: 97